Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.3c03816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Liesl K Janssens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Toxicology, Department of Bioanalysis, Ghent University, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Partnership for Clean Competition, Bijzonder Onderzoeksfonds UGent.
Abstract (Originalsprache)
Hypoxia-inducible factor (HIF) stabilizers are listed in the World Anti-Doping Agency's prohibited list as they can increase aerobic exercise capacity. The rapid pace of emergence of highly structurally diverse HIF stabilizers could pose a risk to conventional structure-based methods in doping control to detect new investigational drugs. Therefore, we developed a strategy that is capable of detecting the presence of any HIF stabilizer, irrespective of its structure, by detecting biological activity. Previously developed cell-based HIF1/2 assays were optimized to a stable format and evaluated for their screening potential toward HIF stabilizers. Improved pharmacological characterization was established by the stable cell-based formats, and broad specificity was demonstrated by pharmacologically characterizing a diverse set of HIF stabilizers (including enarodustat, IOX2, IOX4, MK-8617, JNJ-42041935). The methodological (in solvent) limit of detection of the optimal HIF1 stable bioassay toward detecting the reference compound roxadustat was 100 nM, increasing to 50-100 ng/mL (corresponding to 617-1233 nM in-well) in matching urine samples, owing to strong matrix effects. In a practical context, a urinary limit of detection of 1.15 μg/mL (95% detection rate) was determined, confirming the matrix-dependent detectability of roxadustat in urine. Pending optimization of a universal sample preparation strategy and/or a methodology to correct for the matrix effects, this untargeted approach may serve as a complementing method in antidoping control, as theoretically, it would be capable of detecting any unknown substance with HIF stabilizing activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Toxicology, Department of Bioanalysis, Ghent University, 9000 Ghent, Belgium.
- Doping Control Laboratory, Department Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium.
ORCID-Profile: Laurie De Wilde, Christophe P Stove
Förderung
- Partnership for Clean Competition
- Bijzonder Onderzoeksfonds UGent
Zitieren
APA
Janssens, L. K., De Wilde, L., Van Eenoo, P., & Stove, C. P. (2024). Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c03816
Vancouver
Janssens LK, De Wilde L, Van Eenoo P, Stove CP. Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.3c03816
BibTeX
@article{Janssens2024,
author = {Janssens, Liesl K and De Wilde, Laurie and Van Eenoo, Peter and Stove, Christophe P},
title = {Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.3c03816}
}
EUVIMED